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Introduction: Focal segmental glomerulosclerosis (FSGS) is the most frequent primary glomerulopathy 
in Brazil and its incidence is increasing worldwide. Pathogenesis is related to podocyte injury, which 
may be due to several factors including viruses, drugs, genetics and immunological factors. In 2004, the 
Columbia classification of FSGS identified five histological variants of the disease: collapsing (COL), usual 
(NOS), tip lesion (TIP), perihilar (PHI) and cellular variant (CEL). The objective of this study was to classify 
the FSGS biopsies in these morphological variants. Methods: One hundred thirty-one cases of renal 
biopsies with primary FSGS diagnosis, which had been performed at a Brazilian reference center from 
1996 to 2006, were classified according to the Columbia criteria. Results: FSGS cases were distributed 
as follows: 38.2% NOS variant, 36.6% COL, 14.5% TIP, 6.9% PHI and 3.8% CEL. Conclusion: COL 
variant of FSGS seems to be more prevalent in Brazil in comparison with other centers worldwide, which 
may be related to environmental and socioeconomic factors..
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resumo 
Introdução: A glomerulosclerose segmentar e focal (GESF) é a glomerulopatia primária mais frequente no 
Brasil e sua incidência está aumentando em todo o mundo. Sua patogênese está relacionada com a lesão de 
podócitos, que pode ser devida a vários fatores, incluindo vírus, drogas, fatores genéticos e imunológicos. Em 
2004, a classificação de Columbia GESF definiu cinco variantes histológicas da doença: colapsante (COL), 
usual (NOS), lesão apical (TIP), Peri-hilar (PHI) e variante celular (CEL). O objetivo deste estudo foi classificar 
as biópsias com diagnóstico de GESF nessas variantes morfológicas. Métodos: Cento e trinta e um casos de 
biópsias renais com diagnóstico de GESF primária em um centro brasileiro de referência em nefrologia, no 
período de 1996 a 2006, foram classificados de acordo com os critérios de Columbia. Resultados: Os casos 
se distribuíram da seguinte forma: 38,2% da variante de NOS; 36,6% de COL; 14,5% de TIP; 6,9% de PHI; 
3,8% de CEL. Conclusão: A variante COL de GESF parece ser mais prevalente no Brasil do que em outros 
centros internacionais e isso pode ser reflexo de fatores socioeconômicos e ambientais.
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Introduction 
Focal segmental glomerulosclerosis (FSGS) is a clinical 
and pathological renal syndrome causing proteinuria, 
usually in the nephrotic range, and occurring predominantly 
in young individuals. According to several authors, the 
worldwide incidence of FSGS is on the rise annually, 
including in Brazilian statistics(1, 8, 9). Data from the Paulista 
registry of glomerulopathies shows that FSGS is the most 
common primary glomerulopathy in 11 centers of São Paulo, 
accounting for 29.7% of cases, followed by membranous 
nephropathy (20.7%) and immunoglobulin A (IgA) 
nephropathy (17.8%)(12). From an etiological standpoint, 
FSGS may be associated with a variety of conditions, 
including viral infections (human immunodeficiency virus 
[HIV], simian virus 40 [SV40] , parvovirus B19), several 
drugs (heroin, pamidronate, interferon), adaptive to 
hyperfiltration (as in hypertension, obesity, and sickle-cell 
anemia), and genetic disorders (familiar forms), and may be 
idiopathic(11). Podocyte injury is the core pathophysiological 
event of FSGS and some studies have found anomalous 
expression of podocyte proteins in FSGS(2, 10, 16).
The Columbia classification for primary FSGS, first 
published by D’Agati et al., in 2004, proposed five 
mutually exclusive morphological variants of the disease 
(histologic criteria shown in Table and Figure). Studies 
of these variants demonstrated correlation with distinct 
clinical characteristics and prognostic and therapeutic 
implications(4, 18).
Recognition of these variants through a combination 
of morphologic and molecular features might bring about 
a better understanding of the pathogenesis of FSGS 
and promote identification of new therapeutic targets. 
The present study aimed to classify cases of primary 
FSGS diagnosed at the Divisão de Anatomia Patológica 
do Hospital das Clínicas da Faculdade de Medicina da 
Universidade de São Paulo (DAP-HC-FMUSP) into the 
collapsing (COL), cellular (CEL), usual (NOS),  tip lesion 
(TIP), and perihilar (PHI) morphologic variants.
Methods of case selection
We obtained 525 consecutive biopsies with FSGS 
diagnosis from the archives of the DAP-HC-FMUSP from 
1996 to 2006, of which we selected 131 cases based in the 
following exclusion criteria: 
• secondary FSGS due to known etiology (glomerular 
sclerosis scarring, chronic pyelonephritis, hypertension, 
reflux nephropathy); 
• age below 18 and over 45 years- to guarantee, as 
good as possible, that we were working on primary 
FSGS, once we did not have access to the patient 
charts; 
• less than five glomeruli in a sample  to minimize 
the possibil ity of include focal segmental 
glomerulosclerosis secondary to diabetic 
glomerulopathy, chronic glomerulonephritis etc.; 
• recurrence in kidney allografts; 
• biopsies from HIV seropositive patients; 
• advanced stage of histologic chronicity (more than 
90% of sclerotic glomeruli); 
• biopsies without or with unsatisfactory immuno-
fluorescence; 
• biopsies with positive immunofluorescence for IgA 
and/or IgG in glomeruli. 
Slides and blocks of each case were separated and 
reviewed.
 
Table
 Classification of undiagnosed primary FSGS cases at the DAP-HC-FMUSP. Comparison with other 
published series
HC-FMUSP (1996-2006) North Carolina (1982-2001) Deegens, J. K.(5) (1980-2003)
  n = 131 (%) n = 197 (%) n = 93 (%)
NOS 50 (38,2) 83 (42) 30 (32)
COL 48 (36,6) 22 (11) 5 (5)
CEL 5 (3,8) 6 (3) 0 (0)
TIP 19 (14,5) 34 (17) 34 (37)
PHI 9 (6,9) 52 (26) 24 (26)
PHI + NOS 59 (45,1) 135 (68) 54 (58)
DAP-HC-FMUSP: Divisão de Anatomia Patológica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; FSGS: Focal segmental 
glomerulosclerosis; NOS: usual; COL: collapsing; CEL: cellular; TIP: tip lesion; PHI: perihilar.
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Figure – Working algorithm to FSGS classification
FSGS: focal segmental glomerulosclerosis; COL: collapsing; CEL: cellular; PHI: perihilar; TIP: tip lesion; NOS: usual.
Morphological analysis
Kidney biopsies slides of each case, stained by 
hematoxylin-eosin (HE), periodic acid Schiff (PAS), Masson 
trichrome and methenamine silver (PS Jones), were blindly 
reviewed by two nephropathologists (authors), on which 
were applied the morphologic criteria of Columbia for 
classification of FSGS in the variants: TIP, COL, CEL, PHI 
and NOS. Discordant results were analyzed together by 
the two pathologists to reach consensus.
Results 
After application of the exclusion criteria, a total of 131 
eligible cases remained and were assessed according to 
the histologic criteria proposed by the FSGS classification, 
which revealed 50 cases of NOS; 48, COL; five, CEL; 
19, TIP; and nine, PHI (Table and Figure). The most 
prevalent discrepancy between the authors regarding 
the Columbia classification of FSGS was related to the CEL 
and COL variants, since there were cases previously classified 
as COL that were reclassified as NOS or CEL variant.
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Discussion of results 
Increases in the number of patients with chronic 
kidney disease (CKD) have led to growing interest in a 
better understanding of the renal conditions involved 
in CKD, including FSGS. Improved knowledge of 
pathogenic mechanisms would allow development of 
individualized and more efficient therapeutic actions. 
The recognition of histologic variants can be the first 
step in this direction in the case of primary FSGS, this 
has translated into recent definition of the five variant 
forms of the disease, namely, usual (NOS), collapsing 
(COL), cellular (CEL), perihilar (PHI), and tip lesion (TIP) 
variants. It is now known that certain histologic features 
in FSGS are associated with poor clinical progression, 
including rapid deterioration of renal function and 
marked proteinuria(3, 14, 18). The present series included 
131 cases of primary FSGS diagnosed between 1996 
and 2006, which were classified according to the 
Columbia classification criteria(4) as 50 NOS (38.2%), 
48 COL (36.6%), 19 TIP (14.5%), nine PHI (6.9%), and 
five CEL (3.8%) (Table). Thomas et al.(7) published a 
series of 197 cases recorded at the University of North 
Carolina between 1982 and 2001 and reported that 
42% of cases were of the NOS variant, 17% were TIP, 
13% were COL, 26% were PHI, and 3% were CEL(18) 
(Table). However, we think the authors were less strict 
in selecting cases of primary FSGS than us. Degeens 
et al.(5) observed 32% of NOS, 37% of TIP, 26% of 
PHI, 5% of COL and no CEL variant in an adult Dutch 
population(5). Our data revealed a higher prevalence 
of the COL variant, diverging from the above cited 
case series. These data raise the vision of a possible 
environmental or infectious factor. Given that it is well 
known the bigger incidence in black race and close 
resemblance to HIV-associated nephropathy, a search 
for possible viral etiology and socioeconomic influences 
appears justified. Merlet-Bénichou et al. has found 
reduced numbers of glomeruli and larger glomerular 
volumes in newborn rats exposed to toxins in utero 
and in infants born with small placentas and low birth 
weights; these observations suggest that socioeconomic 
differences, such as poor nutrition or exposure to toxins 
during gestation, might affect the developing kidney 
and result in a reduced glomerular population with 
larger glomerular volume(6, 13).
In the present study, lesions were most easily 
classified into the TIP, NOS, or COL variants using the 
Columbia histological criteria; there was substantial 
overlap of criteria for the NOS and PHI variants, as well 
as with COL and CEL variants. Some authors question 
the existence of a separate CEL variant, and claim it is 
merely a form of the COL variant(17). Others agree that 
both variants are very difficult to distinguish histologically 
and common pathophysiological pathways affecting cell 
cycle regulatory proteins have been established(3, 14, 15). In 
our sample, there was also overlap of histologic findings 
for both variants.
In cases classified as COL, we found the coexistence of 
marked tubulointerstitial injury, sometimes with microcystic 
tubular dilatation, however similar findings were also 
present in other variants, particularly in advanced chronic 
disease, although these changes were more marked in COL 
variant. Therefore, these findings should not be considered 
specific to COL variant FSGS.
The distinction between the NOS and PHI variants 
also seemed unclear when using the current criteria. 
We believe the criterion of > 50% perihilar involvement 
varies according to the level of histological section. 
According to the proposed criteria, the diagnosis of 
PHI variant FSGS should only be considered when 
over 50% of sclerotic glomeruli show perihilar lesions, 
which may vary from one histologic section to another 
of a single biopsy. Several cases classified as NOS 
exhibited perihilar sclerosis and hyalinosis in additional 
sections which highlights the importance of having a 
representative sample in order to distinguish between 
the NOS and PHI variants. Stokes et al. did not include 
cases of the PHI variant in their series, as they believed 
this variant often refers to secondary FSGS, however, 
they found evidence of perihilar lesions in other variants 
mostly in NOS(17). Maybe they found the same difficulty 
in the PHI versus NOS distinction.
In our sample, the TIP variant was particularly difficult 
to diagnose when the apical lesion was represented 
marginally, with no apparent relation to the origin of 
the proximal convoluted tubule, and, in some cases, 
coexisted with morphologic aspects similar to those 
of COL FSGS. These lesions sometimes presenting 
confluence of hypertrophic podocytes, parietal cells, 
and tubular epithelial cells, deformed the glomerular 
tuft, giving it an aspect alike to a collapsing injury. A 
search for classical lesions in contact with the origin 
of the tubule in additional histologic sections and the 
absence of podocyte proliferation can assist in differential 
diagnosis(7).
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Conclusion
In conclusion, the 131 cases of primary FSGS resulted 
in 38.2% NOS variant, 36.6% COL, 14.5% TIP, 6.9% PHI 
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and 3.8% CEL, according to Columbia classification, which 
points to a bigger prevalence of the COL variant than in 
other international centers. Additional studies to better 
explain the socioeconomic role on these prevalences might 
be of value on this field.
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